Clinical Trial Search

Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants

Primary: Intention to Initiate Contraception — 59 Participants

Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05

Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001

Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale

Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants

Primary: Recent PrEP Adherence — 33; 18 Participants — p=<0.001

Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants

Primary: Adolescent Feasibility of Intervention — 4.5; 4.7 score on a scale

Primary: Appointment Adherence (Efficacy) — 34; 28 participants — p=<.05

Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0

Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05

Primary: Maternal HIV Incidence — 0.38; 0.31 incidence/100 Person years

Primary: Continuation at 1 Year — 21; 30 participants

Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants

Primary: Enrollment and Recruitment Rate — 61; 62 Participants

Primary: Estimated Threshold of Maternal Steady-state Tenofovir Diphosphate (TFV-DP) Concentration Levels Corresponding to Optimal Adherence in the PK Component — 965; 1050…

Primary: Number of Participants Who Relapsed by Week 4 Postpartum — 6; 7 participants

Primary: Number of Subjects Experiencing Preterm Birth — 26; 23 Participants

Primary: Implementation Fidelity: Conducting Condom Line-up — 1.67; 1.26 score on an item

Primary: Change in Frequency of Recent Dual Method Use — 3.17; 3.45 score on a scale — p=.177

Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day Rule…

Primary: Number of Patients Who Receive Contraception by Two Months Postpartum — 474; 339 Participants — p=0.12

Primary: Continuation Rates — 82; 78; 83 participants

Primary: PrEP Penetration — 30; 17; 46; 8 Participants

Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants

Primary: 6-Month (183 Days) Cumulative Pregnancy Percentage — 10.0; 10.5 pregnancy percentage

Primary: Contraception Use Self-efficacy Scale Score (Aim 1b) — 23.2; 22.45; 25.22; 23.04 Scores on a scale — p=0.011

Primary: Successful Recruitment and Randomization of 40 Postpartum Women Into the PROMPT Study — 16; 14; 2; 2 Participants

Primary: Adequate Adherence to Study Product — 62; 63 Participants